Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User

May 15, 2015 updated by: Macmillan Research Group UK

Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User: Results of the Randomized Controlled Trial

Substance Use Disorder has been showing a rising trend all over the world including India. The project tested whether a Integrated community wide effort of Prevention and Awareness Groups (PAG) to manage substance use would have a greater effect on treatment attendance and drug abstinence than a de-addiction program alone.

Study Overview

Study Type

Interventional

Enrollment (Actual)

152

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rajasthan
      • Bai, Nawalgarh, Rajasthan, India
        • Gyansanjeevani

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • suburban, rural Population
  • Drug and/or alcohol dependency (DSM-IV substance use disorders criteria)

Exclusion Criteria:

  • Did not consent to participate
  • Planning to move or relocate
  • Severe mental disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Standard Usual Care
Community program which follows with referral services
Experimental: Prevention Awareness Groups (PAG)
Prevention Awareness Groups (PAG) is a community based integrated substance abuse prevention program targeting vulnerable populations. It comprises of community programs, physician led counseling followed by treatment follow up in community based clinic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Treatment attendance
Time Frame: Change from baseline to six month
Change from baseline to six month

Secondary Outcome Measures

Outcome Measure
Time Frame
Drug abstinence
Time Frame: Change from baseline to six month
Change from baseline to six month

Other Outcome Measures

Outcome Measure
Time Frame
Quality of Life assessed by General Health Questionnaire (GHQ)
Time Frame: Change from baseline to six months
Change from baseline to six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Neha Sharma, PhD, NMP Medical Research Institute
  • Study Director: Valerie Murray, MA, Goldington Family Centre
  • Study Chair: Amit Punia, LLB, NMP Medical Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

June 22, 2014

First Submitted That Met QC Criteria

June 22, 2014

First Posted (Estimate)

June 24, 2014

Study Record Updates

Last Update Posted (Estimate)

May 18, 2015

Last Update Submitted That Met QC Criteria

May 15, 2015

Last Verified

May 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Dependence

Clinical Trials on Standard Care

Subscribe